相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Antichagasic, Leishmanicidal, and Trichomonacidal Activity of 2-Benzyl-5-nitroindazole-Derived Amines
Cristina Fonseca-Berzal et al.
CHEMMEDCHEM (2018)
In Vitro and In Vivo Studies of the Trypanocidal Effect of Novel Quinolines
A. S. G. Nefertiti et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Biological factors that impinge on Chagas disease drug development
Amanda F. Francisco et al.
PARASITOLOGY (2017)
Phenotypic evaluation and in silico ADMET properties of novel arylimidamides in acute mouse models of Trypanosoma cruzi infection
Cristiane Franca da Silva et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2017)
Antichagasic and trichomonacidal activity of 1-substituted 2-benzyl-5-nitroindazolin-3-ones and 3-alkoxy-2-benzyl-5-nitro-2H-indazoles
Cristina Fonseca-Berzal et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Biological approaches to characterize the mode of action of two 5-nitroindazolinone prototypes on Trypanosoma cruzi bloodstream trypomastigotes
Cristina Fonseca-Berzal et al.
PARASITOLOGY (2016)
The importance of the multidisciplinary approach to deal with the new epidemiological scenario of Chagas disease (global health)
Maria-Jesus Pinazo et al.
ACTA TROPICA (2015)
A flow cytometer-based method to simultaneously assess activity and selectivity of compounds against the intracellular forms of Trypanosoma cruzi
Cristian Gabriel Miranda et al.
ACTA TROPICA (2015)
Cruzipain: An Update on its Potential as Chemotherapy Target against the Human Pathogen Trypanosoma cruzi
M. H. Branquinha et al.
CURRENT MEDICINAL CHEMISTRY (2015)
Synthesis and evaluation of in vitro and in vivo trypanocidal properties of a new imidazole-containing nitrophthalazine derivative
Francisco Olmo et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
Bond-based bilinear indices for computational discovery of novel trypanosomicidal drug-like compounds through virtual screening
Juan Alberto Castillo-Garit et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
In vitro activity of 1,3-bisaryloxypropanamines against Trypanosoma cruzi-infected L929 cultures
Stefania Neiva Lavorato et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2015)
Translational challenges of animal models in Chagas disease drug development: a review
Eric Chatelain et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2015)
Automated High-Content Assay for Compounds Selectively Toxic to Trypanosoma cruzi in a Myoblastic Cell Line
Julio Alonso-Padilla et al.
PLOS NEGLECTED TROPICAL DISEASES (2015)
Trypanocidal effect of the benzyl ester of N-propyl oxamate: a bi-potential prodrug for the treatment of experimental Chagas disease
Carlos Wong-Baeza et al.
BMC PHARMACOLOGY & TOXICOLOGY (2015)
A Novel Method for Inducing Amastigote-To-Trypomastigote Transformation In Vitro in Trypanosoma cruzi Reveals the Importance of Inositol 1,4,5-Trisphosphate Receptor
Muneaki Hashimoto et al.
PLOS ONE (2015)
A New Experimental Model for Assessing Drug Efficacy against Trypanosoma cruzi Infection Based on Highly Sensitive In Vivo Imaging
Michael D. Lewis et al.
JOURNAL OF BIOMOLECULAR SCREENING (2015)
Chagas Disease Drug Discovery: Toward a New Era
Eric Chatelain
JOURNAL OF BIOMOLECULAR SCREENING (2015)
Antitrypanosomal Activity of Fexinidazole Metabolites, Potential New Drug Candidates for Chagas Disease
Maria T. Bahia et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
In Vitro and In Vivo Biological Effects of Novel Arylimidamide Derivatives against Trypanosoma cruzi
Bruno Lisboa Timm et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Bioluminescence imaging of chronic Trypanosoma cruzi infections reveals tissue-specific parasite dynamics and heart disease in the absence of locally persistent infection
Michael D. Lewis et al.
CELLULAR MICROBIOLOGY (2014)
New perspectives on the synthesis and antichagasic activity of 3-alkoxy-1-alkyl-5-nitroindazoles
Beatriz Muro et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
Therapeutical approaches under investigation for treatment of Chagas disease
Maria Terezinha Bahia et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2014)
Binding Mode and Potency of N-Indolyloxopyridinyl-4-aminopropanyl-Based Inhibitors Targeting Trypanosoma cruzi CYP51
Debora F. Vieira et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
In vivo imaging of mice infected with bioluminescent Trypanosoma cruzi unveils novel sites of infection
Cristina Henriques et al.
PARASITES & VECTORS (2014)
In vitro and in vivo activity of the chloroaryl-substituted imidazole viniconazole against Trypanosoma cruzi
Cristiane Franca Da Silva et al.
PARASITOLOGY (2014)
Screening strategies to identify new chemical diversity for drug development to treat kinetoplastid infections
Rob Don et al.
PARASITOLOGY (2014)
Further insights into biological evaluation of new anti-Trypanosoma cruzi 5-nitroindazoles
Cristina Fonseca-Berzal et al.
PARASITOLOGY RESEARCH (2014)
The present situation, challenges, and perspectives regarding the production and utilization of effective drugs against human Chagas disease
Joao Carlos Pinto Dias et al.
REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL (2014)
Nitroheterocyclic compounds are more efficacious than CYP51 inhibitors against Trypanosoma cruzi: implications for Chagas disease drug discovery and development
Carolina B. Moraes et al.
SCIENTIFIC REPORTS (2014)
Synergy Testing of FDA-Approved Drugs Identifies Potent Drug Combinations against Trypanosoma cruzi
Joseph D. Planer et al.
PLOS NEGLECTED TROPICAL DISEASES (2014)
The natural compounds piperovatine and piperlonguminine induce autophagic cell death on Trypanosoma cruzi
Phercyles Veiga-Santos et al.
ACTA TROPICA (2013)
In Vitro and In Vivo Studies of the Antiparasitic Activity of Sterol 14α-Demethylase (CYP51) Inhibitor VNI against Drug-Resistant Strains of Trypanosoma cruzi
Maria de Nazare Correia Soeiro et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Trypanosoma cruzi mitochondrial swelling and membrane potential collapse as primary evidence of the mode of action of naphthoquinone analogues
Kelly Salomao et al.
BMC MICROBIOLOGY (2013)
VNI Cures Acute and Chronic Experimental Chagas Disease
Fernando Villalta et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Approaches to Protozoan Drug Discovery: Phenotypic Screening
Melissa L. Sykes et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Two Analogues of Fenarimol Show Curative Activity in an Experimental Model of Chagas Disease
Martine Keenan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Use of clomipramine as chemotherapy of the chronic phase of Chagas disease
Romina Fauro et al.
PARASITOLOGY (2013)
Stage-Regulated GFP Expression in Trypanosoma cruzi: Applications from Host-Parasite Interactions to Drug Screening
Rafael Luis Kessler et al.
PLOS ONE (2013)
Identification In Silico and In Vitro of Novel Trypanosomicidal Drug-Like Compounds
Juan A. Castillo-Garit et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2012)
Synthesis, biological evaluation and chemometric analysis of indazole derivatives. 1,2-Disubstituted 5-nitroindazolinones, new prototypes of antichagasic drug
Maria Celeste Vega et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2012)
The revised Trypanosoma cruzi subspecific nomenclature: Rationale, epidemiological relevance and research applications
Bianca Zingales et al.
INFECTION GENETICS AND EVOLUTION (2012)
Cardiomyopathy prognosis after benznidazole treatment in chronic canine Chagas' disease
Fabiane M. Santos et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
A fluorometric method for evaluation of pharmacological activity against intracellular Leishmania amastigotes
Pablo Bilbao-Ramos et al.
JOURNAL OF MICROBIOLOGICAL METHODS (2012)
A novel triazolic naphthofuranquinone induces autophagy in reservosomes and impairment of mitosis in Trypanosoma cruzi
M. C. Fernandes et al.
PARASITOLOGY (2012)
Fexinidazole: A Potential New Drug Candidate for Chagas Disease
Maria Terezinha Bahia et al.
PLOS NEGLECTED TROPICAL DISEASES (2012)
Hematological alterations during experimental canine infection by Trypanosoma cruzi
Paulo Marcos Matta Guedes et al.
REVISTA BRASILEIRA DE PARASITOLOGIA VETERINARIA (2012)
Synthesis of 2-Hydrazolyl-4-Thiazolidinones Based on Multicomponent Reactions and Biological Evaluation Against Trypanosoma Cruzi
Chiara Pizzo et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2011)
Ligand-based discovery of novel trypanosomicidal drug-like compounds: In silico identification and experimental support
Juan Alberto Castillo-Garit et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2011)
Methodological advances in drug discovery for Chagas disease
Juan M. Bustamante et al.
EXPERT OPINION ON DRUG DISCOVERY (2011)
Current status of Chagas disease chemotherapy
Paulo M. M. Guedes et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2011)
Potent 5-nitrofuran derivatives inhibitors of Trypanosoma cruzi growth: Electrochemical, spectroscopic and biological studies
C. Maria Aravena et al.
SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY (2011)
3D-QSAR studies on purine-carbonitriles as cruzain inhibitors: comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA)
Oscar Mendez-Lucio et al.
MEDCHEMCOMM (2011)
Activity In Vivo of Anti-Trypanosoma cruzi Compounds Selected from a High Throughput Screening
Grasiella Andriani et al.
PLOS NEGLECTED TROPICAL DISEASES (2011)
Chagas disease in Spain, the United States and other non-endemic countries
Joaquim Gascon et al.
ACTA TROPICA (2010)
Trypanocidal Activity of Aziridinyl Nitrobenzamide Prodrugs
Chris Bot et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Arylimidamide DB766, a Potential Chemotherapeutic Candidate for Chagas' Disease Treatment
Denise da Gama Jaen Batista et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Mode of action of Nifurtimox and N-oxide-containing heterocycles against Trypanosoma cruzi: Is oxidative stress involved?
Mariana Boiani et al.
BIOCHEMICAL PHARMACOLOGY (2010)
3D-QSAR in Drug Design - A Review
Jitender Verma et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2010)
Computational discovery of novel trypanosomicidal drug-like chemicals by using bond-based non-stochastic and stochastic quadratic maps and linear discriminant analysis
Juan Alberto Castillo-Garit et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2010)
The anticancer drug tamoxifen is active against Trypanosoma cruzi in vitro but ineffective in the treatment of the acute phase of Chagas disease in mice
Danilo Ciccone Miguel et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2010)
In vitro and in vivo experimental models for drug screening and development for Chagas disease
Alvaro Jose Romanha et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2010)
In Vitro and In Vivo High-Throughput Assays for the Testing of Anti-Trypanosoma cruzi Compounds
Adriana M. C. Canavaci et al.
PLOS NEGLECTED TROPICAL DISEASES (2010)
Study of 5-nitroindazoles' anti-Trypanosoma cruzi mode of action: Electrochemical behaviour and ESR spectroscopic studies
Jorge Rodriguez et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2009)
Present situation and new strategies for Chagas disease chemotherapy - a proposal
Jose Rodrigues Coura
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2009)
A new consensus for Trypanosoma cruzi intraspecific nomenclature: second revision meeting recommends TcI to TcVI
B. Zingales et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2009)
Identification of Three Classes of Heteroaromatic Compounds with Activity against Intracellular Trypanosoma cruzi by Chemical Library Screening
Esther Bettiol et al.
PLOS NEGLECTED TROPICAL DISEASES (2009)
In vitro and in vivo studies of the trypanocidal activity of a diarylthiophene diamidine against Trypanosoma cruzi
Cristiane Franca da Silva et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Trypanosoma cruzi:: Activities of lapachol and α- and β-lapachone derivatives against epimastigote and trypomastigote forms
Cristian Salas et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2008)
Activity of a hydroxybibenzyl bryophyte constituent against Leishmania spp. and Trypanosoma cruzi: In silico, in vitro and in vivo activity studies
Virginia Roldos et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2008)
Treatment with benznidazole or thioridazine in the chronic phase of experimental Chagas disease improves cardiopathy
Juan M. Bustamante et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2007)
In vitro and in vivo activity of lignan lactones derivatives against Trypanosoma cruzi
Juliana Saraiva et al.
PARASITOLOGY RESEARCH (2007)
In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
S. Ekins et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Similarity-based virtual screening using 2D fingerprints
Peter Willett
DRUG DISCOVERY TODAY (2006)
Ultrastructural analysis of edelfosine-treated trypomastigotes and amastigotes of Trypanosoma cruzi
R. M. Santa-Rita et al.
PARASITOLOGY RESEARCH (2006)
Evolution and pathology in Chagas disease - A review
Antonio R. L. Teixeira et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2006)
Selective activity of polyene macrolides produced by genetically modified Streptomyces on Trypanosoma cruzi
Miriam Rolon et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2006)
Development of resazurin microtiter assay for drug sensibility testing of Trypanosoma cruzi epimastigotes
Miriam Rolón et al.
PARASITOLOGY RESEARCH (2006)
2H-benzimidazole 1,3-dioxide derivatives:: A new family of water-soluble anti-trypanosomatid agents
Mariana Boiani et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
New ligand-based approach for the discovery of antitrypanosomal compounds
MC Vega et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
Antiparasitic properties of homoallylamines and related compounds
A Gómez-Barrio et al.
ACTA PARASITOLOGICA (2006)
Computational methods in developing quantitative structure-activity relationships (QSAR):: A review
AZ Dudek et al.
COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING (2006)
Inhibition of Trypanosoma cruzi hexokinase by bisphosphonates
MP Hudock et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
A novel non-stochastic quadratic fingerprints-based approach for the 'in silico' discovery of new antitrypanosomal compounds
A Montero-Torres et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2005)
Design, synthesis and evaluation of 2,4-diaminoquinazolines as inhibitors of trypanosomal and leishmanial dihydrofolate reductase
S Khabnadideh et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2005)
A new pharmacological screening assay with Trypanosoma cruzi epimastigotes expressing β-galactosidase
C Vega et al.
PARASITOLOGY RESEARCH (2005)
Cell lines as in vitro models for drug screening and toxicity studies
DD Allen et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2005)
Biological characterization of a β-galactosidase expressing clone of Trypanosoma cruzi CL strain
A Le-Senne et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2002)
Production of amastigotes from metacyclic trypomastigotes of Trypanosoma cruzi
VT Contreras et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2002)
The dog as model for chemotherapy of the Chagas' disease
PMD Guedes et al.
ACTA TROPICA (2002)
A critical review on Chagas disease chemotherapy
JR Coura et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2002)
In vitro and in vivo assays of 3,5-disubstituted-tetrahydro-2H-1,3,5-thiadiazin-2-thione derivatives against Trypanosoma cruzi
S Muelas et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2002)
Biological characterization of Trypanosoma cruzi strains
RA Martinez-Diaz et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2001)
New thiadiazine derivatives with activity against Trypanosoma cruzi amastigotes
S Muelas et al.
FOLIA PARASITOLOGICA (2001)
Setting of a colorimetric method to determine the viability of Trypanosoma cruzi epimastigotes
S Muelas-Serrano et al.
PARASITOLOGY RESEARCH (2000)
分享论文
